Geneoscopy, Inc
St. Louis, US · Founded 2019 · Delaware corporation · 79 employees on LinkedIn · 5 known investors
Find your way into Geneoscopy, Inc
599 people in our graph share verified history with the Geneoscopy, Inc team — schools, employers, funds. One of them is your warm intro.
Mike Zakunlockedknows Erica Barnell · together at Cornell (overlapped)
×6knows the team · via Cornell
×2knows the team · via Conde Nast
knows the team · via The Wharton School
knows the team · via Washington University School of Medicine in St. Louis
knows the team · via Donald Danforth Plant Science Center
Geneoscopy develops innovative diagnostic technologies for gastrointestinal health, specifically focused on the detection of colorectal cancer. The company serves healthcare providers and patients seeking advanced diagnostic solutions in the medical diagnostics and cancer detection sector.
Founders & leadership
Geneoscopy, Inc was founded in 2019 by Andrew Barnell and Erica Barnell.
AB
Andrew BarnellinChief Executive Officer & Co-founderCo-founder and CEO of Geneoscopy, a molecular diagnostics company developing technologies to detect and treat gastrointestinal diseases, including colorectal cancer.
EB
Erica BarnellinCo-founderErica Barnell is a physician-scientist and the co-founder and Chief Medical Officer of Geneoscopy, which develops RNA-based diagnostics for gastrointestinal conditions such as colorectal cancer and inflammatory bowel disease. She holds an MD and a PhD in Bioinformatics from Washington University School of Medicine and has authored over 30 peer-reviewed publications, four book chapters, and multiple patents in precision medicine.
Investors · 5
Funding
SEC filings, press & company announcements$163.4M disclosed across 3 of 4 rounds · 2019–2025
▶$50.5MraisedNov 2021 · 85 investors · Other Health CareRule 506(b)
▶$50.5MraisedNov 2021 · 85 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- JAMES MERSELISDirector
- ERICA BARNELLExecutive Officer, Director
- NAJEEB THOMASDirector
- ANDREW BARNELLExecutive Officer, Director
- MARK ZORENSKYDirector
- DREW DENNISONDirector
- BOBBY W. SANDAGE, JR.Director
- Offering amount
- $50.5M
- Amount sold
- $50.5M
- Minimum investment
- $1
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$7.9MraisedSep 2019 · 57 investors · Other Health CareRule 506(b)
▶$7.9MraisedSep 2019 · 57 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- ANDREW BARNELLExecutive Officer, Director
- Offering amount
- $7.9M
- Amount sold
- $7.9M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlapAmerican Cancer Society (ACS)17 shared keywordsThe American Cancer Society is a nonprofit organization that provides cancer research updates, screening and prevention guidance, and community engagement opportunities. It serves individuals seeking cancer information and those who want to support cancer research and patient advocacy efforts.
Labcorp14 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Uclahealth12 shared keywordsUCLA Health is a major academic health system providing patient care across five hospitals and 290 clinics in Southern California and the Central Coast, alongside research and medical education. The organization conducts pioneering research in oncology, transplantation, neurosurgery, and other specialties, having contributed to the development of numerous FDA-approved treatments.
Rf Surgical11 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Boston Scientific10 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Medscape9 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Companies competing with Geneoscopy, Inc for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Geneoscopy, Inc do?
- Geneoscopy develops innovative diagnostic technologies for gastrointestinal health, specifically focused on the detection of colorectal cancer. The company serves healthcare providers and patients seeking advanced diagnostic solutions in the medical diagnostics and cancer detection sector.
- Who founded Geneoscopy, Inc?
- Geneoscopy, Inc was founded by Andrew Barnell, Erica Barnell in 2019.
- Who are Geneoscopy, Inc's investors?
- Geneoscopy, Inc's investors include BioGenerator Ventures, Dorm Room, iSelect Fund, Missouri Technology Corporation, Cultivation Capital.
- How much funding has Geneoscopy, Inc raised?
- Geneoscopy, Inc has disclosed $163.4M raised across 3 of its 4 known rounds.
- Where is Geneoscopy, Inc headquartered?
- Geneoscopy, Inc is headquartered in St. Louis, US.